Since this process is accompanied by increased expression of the immune checkpoint protein programmed cell death ligand 1 (PDL1) on both T-cell infiltrates and tumor cells, PDL1 inhibitors have been developed and approved for cancer treatment [68,69]. Here, CD274 is linked to cancer.